Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ

INTRODUCTION: Interferon-β (IFNß) is the first-line treatment for relapsing-remitting multiple sclerosis. Myxovirus resistance protein A (MxA) is a marker of IFNß bioactivity, which may be reduced by neutralizing antibodies (NAbs) against IFNß. The aim of the study was to analyze the kinetics of MxA...

Descripción completa

Detalles Bibliográficos
Autores principales: Libertinova, Jana, Meluzinova, Eva, Tomek, Ales, Horakova, Dana, Kovarova, Ivana, Matoska, Vaclav, Kumstyrova, Simona, Zajac, Miroslav, Hyncicova, Eva, Liskova, Petra, Houzvickova, Eva, Martinkovic, Lukas, Bojar, Martin, Havrdova, Eva, Marusic, Petr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231341/
https://www.ncbi.nlm.nih.gov/pubmed/28081207
http://dx.doi.org/10.1371/journal.pone.0169957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231341/
https://www.ncbi.nlm.nih.gov/pubmed/28081207
http://dx.doi.org/10.1371/journal.pone.0169957

Ejemplares similares